TBC-4746

N/A

Report date: 2022/01/24 16:50:28
NME

Base Information

Drug NameTBC-4746
Drug Alias NameAVA-4746TBC-4746
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-1 inhibitorsVascular cell adhesion molecule 1 inhibitors
TargetsIntegrin alpha-V/beta-1Vascular cell adhesion molecule 1
Therapy Area/IndicationsMultiple SclerosisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme CorpPfizer Inc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisAsthma

Other Information

ATC CodeN/A
Related LinksN/A